JAZZ · Jazz Pharmaceuticals plc

$244.96 -0.89 (-0.36%) At close · Aug 14

Market Cap

$15.90B

64.91M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$500,000,000

as of 2025-06-30 · from 8-K (reviewed)

Remaining Authorization

$225,000,000

as of 2026-06-30

Program Utilization

55.0% $275,000,000 used of $500,000,000

Program Announced	Authorized	Remaining	As of	Runs Through	Source
—	$500,000,000	$225,000,000	2025-06-30	—	8-K , filed 2025-08-05

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2026-06-30 YTD	$0	—	—	10-Q, filed 2026-08-03
2025-12-31	$125,023,000	—	—	10-K, filed 2026-02-24
2024-12-31	$311,429,000	—	—	10-K, filed 2026-02-24
2023-12-31	$269,761,000	—	—	10-K, filed 2026-02-24
2022-12-31	$54,000	—	—	10-K, filed 2025-02-26
2021-12-31	$0	—	—	10-K, filed 2024-02-28
2020-12-31	$146,537,000	—	—	10-K, filed 2023-03-01
2019-12-31	$301,450,000	—	—	10-K, filed 2022-03-01
2018-12-31	$523,672,000	—	—	10-K, filed 2021-02-23
2017-12-31	$98,799,000	—	—	10-K, filed 2020-02-25
2016-12-31	$278,296,000	—	—	10-K, filed 2019-02-26
2015-12-31	$61,553,000	—	—	10-K, filed 2018-02-27
2014-12-31	$42,215,000	—	—	10-K, filed 2017-02-28
2013-12-31	$136,484,000	—	—	10-K, filed 2016-02-23

2012-12-31	$0	—	—	10-K, filed 2015-02-24
2011-12-31	$0	—	—	10-K, filed 2014-02-25

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2025-12-31	$0 Δ	—	—	10-K, filed 2026-02-24
2025-09-30	$23,000 Δ	—	—	10-Q, filed 2025-11-05
2024-12-31	$0 Δ	—	—	10-K, filed 2026-02-24
2024-09-30	$150,001,000 Δ	—	—	10-Q, filed 2025-11-05
2023-12-31	$99,795,000 Δ	—	—	10-K, filed 2026-02-24
2023-09-30	$74,371,000 Δ	—	—	10-Q, filed 2024-11-07
2022-12-31	$0 Δ	—	—	10-K, filed 2025-02-26
2022-09-30	$0 Δ	—	—	10-Q, filed 2023-11-08
2021-12-31	$0 Δ	—	—	10-K, filed 2024-02-28
2021-09-30	$0 Δ	—	—	10-Q, filed 2022-11-09
2021-06-30	$0 Δ	—	—	10-Q, filed 2022-08-03
2021-03-31	$0	—	—	10-Q, filed 2021-05-04

Key facts CIK 1232524 CUSIP G50871105 13F (30d) 593 filings 570 filers Visit website Investor relations